关键信息
-
基因名
LNPEP
- 应用
-
别名
CAP; PLAP; OTASE; IRAP; Oxytocinase; Insulin-regulated membrane aminopeptidase; Insulin-responsive aminopeptidase; Placental leucine aminopeptidase
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UIQ6
-
表达区间
Leu782~Leu1025
-
分子量
28kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
LNPEP, or leucine aminopeptidase, is an essential enzyme involved in the regulation of various physiological processes, including protein metabolism and immune responses. Its role in processing peptides by removing N-terminal leucine residues makes it vital for the maturation of bioactive peptides and hormones. Research into LNPEP has gained momentum due to its implications in various diseases, particularly those related to metabolic and neurodegenerative disorders. Studies have demonstrated that dysregulation of LNPEP activity can lead to abnormal peptide accumulation and contribute to pathological conditions such as Alzheimer's disease and hypertension. As a result, the development and characterization of recombinant LNPEP are essential for understanding its biological functions and therapeutic potential. Through recombinant DNA technology, researchers can produce large quantities of LNPEP, enabling detailed biochemical studies and high-throughput screening for potential inhibitors or modulators. This work not only aids in elucidating the enzyme's mechanisms but also identifies LNPEP as a potential biomarker and therapeutic target. Given the enzyme's significance in maintaining cellular homeostasis and its involvement in disease mechanisms, continued exploration into recombinant LNPEP may yield valuable insights into novel treatment strategies and therapeutic applications.
